Analysts Expect Breakeven For Ping An Healthcare and Technology Company Limited (HKG:1833)

By
Simply Wall St
Published
March 03, 2020
SEHK:1833

Ping An Healthcare and Technology Company Limited's (HKG:1833): Ping An Healthcare and Technology Company Limited operates an Internet healthcare platform in the People's Republic of China. The HK$81b market-cap company announced a latest loss of -CN¥733.9m on 31 December 2019 for its most recent financial year result. Many investors are wondering the rate at which 1833 will turn a profit, with the big question being “when will the company breakeven?” In this article, I will touch on the expectations for 1833’s growth and when analysts expect the company to become profitable.

View our latest analysis for Ping An Healthcare and Technology

Consensus from the 5 Healthcare Services analysts is 1833 is on the verge of breakeven. They expect the company to post a final loss in 2020, before turning a profit of CN¥299m in 2021. 1833 is therefore projected to breakeven around a few months from now. In order to meet this breakeven date, I calculated the rate at which 1833 must grow year-on-year. It turns out an average annual growth rate of 91% is expected, which is extremely buoyant. Should the business grow at a slower rate, it will become profitable at a later date than expected.

SEHK:1833 Past and Future Earnings, March 3rd 2020
SEHK:1833 Past and Future Earnings, March 3rd 2020

Given this is a high-level overview, I won’t go into details of 1833’s upcoming projects, however, keep in mind that typically healthcare tech companies, depending on the stage of product development, have irregular periods of cash flow. This means, large upcoming growth rates are not abnormal as the company is beginning to reap the benefits of earlier investments.

One thing I’d like to point out is that 1833 has no debt on its balance sheet, which is quite unusual for a cash-burning healthcare tech company, which usually has a high level of debt relative to its equity. This means that 1833 has been operating purely on its equity investment and has no debt burden. This aspect reduces the risk around investing in the loss-making company.

Next Steps:

There are too many aspects of 1833 to cover in one brief article, but the key fundamentals for the company can all be found in one place – 1833’s company page on Simply Wall St. I’ve also compiled a list of pertinent aspects you should look at:

  1. Valuation: What is 1833 worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether 1833 is currently mispriced by the market.
  2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Ping An Healthcare and Technology’s board and the CEO’s back ground.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

Discounted cash flow calculation for every stock

Simply Wall St does a detailed discounted cash flow calculation every 6 hours for every stock on the market, so if you want to find the intrinsic value of any company just search here. It’s FREE.


Simply Wall St character - Warren

Simply Wall St

Simply Wall St is a financial technology startup focused on providing unbiased, high-quality research coverage on every listed company in the world. Our research team consists of equity analysts with a public, market-beating track record. Learn more about the team behind Simply Wall St.